Assessment of Cell-Cycle Arrest Biomarkers to Predict Early and Delayed Acute Kidney Injury

Table 2

Urinary biomarker levels on admission in non-AKI patients and in patients who develop AKI within 12, 24, and 48 hours.

	No AKI; ( = 75)	AKI within; 12 h	AKI within; 12–24 h	AKI within; 24–48 h
		( = 8)	( = 4)	( = 7)
TIMP-2 × IGFBP7, (g/mL)^2/1000	0.19 (0.07, 0.51)	0.08 (0.02, 1.30)	0.08 (0.03, 0.68)	0.15 (0.03, 0.40)	0.58
NGAL, ng/mL	10 (3.8, 32)	25 (1.6, 248)	11 (5.5, 30)	7.9 (3.8, 21)	0.95
Cystatin C, mg/L	0.22 (0.09, 0.75)	0.25 (0.01, 4.50)	0.28 (0.15, 0.37)	0.19 (0.07, 0.67)	0.82

Values are median (interquartile range).